Research lays groundwork for promising new gene therapy approach for genetic heart disease: Clinical trials imminent
Researchers at the Hubrecht Institute have laid the foundation for the development of a gene therapy for the genetic heart disease arrhythmogenic cardiomyopathy (ACM). Their approach, based on replacement of the PKP2 gene, ...
Dec 7, 2023
0
63